Abstract
Background: Resting-state functional magnetic resonance imaging (RS-fMRI) appears as a promising imaging technique to identify early biomarkers of Alzheimer type neurodegeneration, which can be more sensitive to detect the earliest stages of this disease than structural alterations. Recent findings have highlighted interesting patterns of alteration in resting-state activity at the mild cognitive impairment (MCI) prodromal stage of Alzheimer’s disease. However, it has not been established whether RS-fMRI alterations may be of any diagnostic use at the individual patient level and whether parameters derived from RS-fMRI images add any quantitative predictive/classificatory value to standard cognitive tests (CTs). Methods: We computed a set of 444 features based on RS-fMRI and used 21 variables obtained from a neuropsychological assessment battery of tests in 29 MCI patients and 21 healthy controls. We used these indices to evaluate their impact on MCI/healthy control classification using machine learning algorithms and a 10-fold cross validation analysis. Results: A classification accuracy (sensitivity/ specificity/area under curve/positive predictive value/negative predictive value) of 0.9559 (0.9620/0.9470/ 0.9517/0.9720/0.9628) was achieved when using both sets of indices. There was a statistically significant improvement over the use of CTs only, highlighting the superior classificatory role of RS-fMRI. Conclusions: RS-fMRI provides complementary information to CTs for MCI-patient/healthy control individual classification.
Keywords: Accuracy, AD, biomarker, classification, mild cognitive impairment, MCI, neurodegeneration.
Current Alzheimer Research
Title:Integration of Cognitive Tests and Resting State fMRI for the Individual Identification of Mild Cognitive Impairment
Volume: 12 Issue: 6
Author(s): Leandro Beltrachini, Matteo De Marco, Zeike A. Taylor, Jyrki Lotjonen, Alejandro F. Frangi and Annalena Venneri
Affiliation:
Keywords: Accuracy, AD, biomarker, classification, mild cognitive impairment, MCI, neurodegeneration.
Abstract: Background: Resting-state functional magnetic resonance imaging (RS-fMRI) appears as a promising imaging technique to identify early biomarkers of Alzheimer type neurodegeneration, which can be more sensitive to detect the earliest stages of this disease than structural alterations. Recent findings have highlighted interesting patterns of alteration in resting-state activity at the mild cognitive impairment (MCI) prodromal stage of Alzheimer’s disease. However, it has not been established whether RS-fMRI alterations may be of any diagnostic use at the individual patient level and whether parameters derived from RS-fMRI images add any quantitative predictive/classificatory value to standard cognitive tests (CTs). Methods: We computed a set of 444 features based on RS-fMRI and used 21 variables obtained from a neuropsychological assessment battery of tests in 29 MCI patients and 21 healthy controls. We used these indices to evaluate their impact on MCI/healthy control classification using machine learning algorithms and a 10-fold cross validation analysis. Results: A classification accuracy (sensitivity/ specificity/area under curve/positive predictive value/negative predictive value) of 0.9559 (0.9620/0.9470/ 0.9517/0.9720/0.9628) was achieved when using both sets of indices. There was a statistically significant improvement over the use of CTs only, highlighting the superior classificatory role of RS-fMRI. Conclusions: RS-fMRI provides complementary information to CTs for MCI-patient/healthy control individual classification.
Export Options
About this article
Cite this article as:
Beltrachini Leandro, Marco De Matteo, Taylor A. Zeike, Lotjonen Jyrki, Frangi F. Alejandro and Venneri Annalena, Integration of Cognitive Tests and Resting State fMRI for the Individual Identification of Mild Cognitive Impairment, Current Alzheimer Research 2015; 12 (6) . https://dx.doi.org/10.2174/156720501206150716120332
DOI https://dx.doi.org/10.2174/156720501206150716120332 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
New Advances in the Prevention, Diagnosis, Treatment, and Rehabilitation of Alzheimer's Disease
Aims and Scope: Introduction: Alzheimer's disease (AD) poses a significant global health challenge, with an increasing prevalence that demands concerted efforts to advance our understanding and strategies for prevention, diagnosis, treatment, and rehabilitation. This thematic issue aims to bring together cutting-edge research and innovative approaches from multidisciplinary perspectives to address ...read more
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer?s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Deep Learning for Advancing Alzheimer's Disease Research
Alzheimer's disease (AD) poses a significant global health challenge, with an increasing number of individuals affected yearly. Deep learning, a subfield of artificial intelligence, has shown immense potential in various domains, including healthcare. This thematic issue of Current Alzheimer Research explores the application of deep learning techniques in advancing our ...read more
Diagnostic and therapeutic biomarkers of dementia
Dementia affects 18 million people worldwide. Dementia is a syndrome of symptoms caused by brain disease, usually chronic or progressive, clinically characterized by multiple impairments of higher cortical functions such as memory, thinking, orientation, and learning. In addition, in the course of dementia, cognitive deficits are observed, which often hinder ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Apo-E4 Allele in Conjunction with Aβ42 and Tau in CSF: Biomarker for Alzheimers Disease
Current Alzheimer Research From Cerebrospinal Fluid Pulsation to Noninvasive Intracranial Compliance and Pressure Measured by MRI Flow Studies
Current Medical Imaging Near Infrared Optical Technologies to Illuminate the Status of the Neonatal Brain
Current Pediatric Reviews Intracranial Non-traumatic Aneurysms in Children and Adolescents
Current Pediatric Reviews Viral Encephalitis: Current Treatments and Future Perspectives
Central Nervous System Agents in Medicinal Chemistry Copy Number Variations with Isolated Fetal Ventriculomegaly
Current Molecular Medicine The Role of Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease Diagnosis. Where are we Now?
Recent Patents on CNS Drug Discovery (Discontinued) Calcitonin Gene-Related Family Peptides in Vascular Adaptations, Uteroplacental Circulation, and Fetal Growth
Current Vascular Pharmacology Catatonia Due to a General Medical Condition (Organic Catatonia)
Current Psychiatry Reviews Single Amino Acid Repeats Connect Viruses to Neurodegeneration
Current Drug Discovery Technologies Role of COL4A1 in Basement-Membrane Integrity and Cerebral Small-Vessel Disease. The COL4A1 Stroke Syndrome
Current Medicinal Chemistry BDNF Serum Concentrations Show No Relationship with Diagnostic Group or Medication Status in Neurodegenerative Disease
Current Alzheimer Research Recent Advances in Nanotechnology-Based Drug Delivery Approaches for Alzheimer disease
Current Drug Targets Review of Pediatric Uveitis
Current Pediatric Reviews Outcome Prediction after Non-aneurysmal Non-traumatic Subarachnoid Hemorrhage
Current Neurovascular Research Aligning Animal Models of Clinical Germinal Matrix Hemorrhage, From Basic Correlation to Therapeutic Approach
Current Drug Targets Anesthesia Issues in Central Nervous System Disorders
Current Aging Science Complications of Paget Bone Disease: A Study of 69 Patients
Current Rheumatology Reviews Role of Psychiatrists in the Diagnosis and Management of Alzheimer's Disease “Revisited”: A Review and Clinical Opinion
Current Psychiatry Reviews Early Brain Injury or Vasospasm? An Overview of Common Mechanisms
Current Drug Targets